Selective calculation revealed that for AML patients expressing FLT3 WT, high expression of TGF-β1 was associated with a better prognosis, while it was mainly detrimental in FLT3 ITD-positive AML (Supplementary Materials Table S3, Figure 3d). This evidence concerns the gene TGFB1 and acute myeloid leukemia.